Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Lichenoid Dermatitis with Mycosis Fungoides Features Linked to Checkpoint Inhibitor Therapy
Key clinical point: Lichenoid dermatitis with mycosis fungoides–like features can be an adverse side effect of checkpoint inhibitors.
Major finding: Checkpoint inhibitor therapy can trigger lichenoid dermatitis with mycosis fungoides–like features.
Study details: A case report involving a 66-year-old man with BRAFV600E-mutated anaplastic thyroid carcinoma.
Disclosures: The researchers did not report financial disclosures.
Source: Tetzlaff MT et al. J Cutan Pathol. 2019 Jun 29. doi: 10.1111/cup.13536.
Citation:
Tetzlaff MT et al. J Cutan Pathol. 2019 Jun 29. doi: 10.1111/cup.13536.